Skip to nav Skip to content

Moffitt’s multispecialty Blood and Marrow Transplant and Cellular Immunotherapy team

If your medical team has suggested that you consider a bone marrow transplant, a specialist in the Blood and Marrow Transplant and Cellular Immunotherapy Program at Moffitt Cancer Center can help you decide whether this complex treatment is the right next step for you. As a National Marrow Donor Program (NMDP) transplant and collection center, Moffitt performs transplants to treat cancers that affect blood-forming tissues, such as leukemia and lymphoma, as well as to restore stem cells that were damaged or destroyed by high-dose chemotherapy or radiation treatment.

At Moffitt, we believe that cancer treatment must be highly individualized to reach its full potential. Therefore, we will provide you with opportunities to work one-on-one with a blood and bone marrow transplant specialist. In addition, you will also benefit from multiple expert opinions throughout your treatment journey. That’s because we emphasize teamwork, knowing that our accomplishments as a group can far exceed those of any single team member working alone. Through our unique multispecialty approach, we are able to truly optimize each patient's journey to ensure the best possible outcomes and quality of life.

Each specialist on Moffitt’s multispecialty Blood and Marrow Transplant and Cellular Immunotherapy team focuses exclusively on blood and bone marrow transplants. These experienced medical professionals include:

  • Physicians
  •  Advanced practice providers
  •  Nurses
  •  Transplant coordinators
  •  Pharmacists
  •  Clinical trial coordinators
  •  Social workers
  •  Apheresis specialists

Throughout the transplant process, a BMT transplant specialist will see you on a daily basis to perform examinations, evaluate your progress, keep you informed and answer any questions you may have. Remember, you will be one of the most important members of your treatment team, and we will encourage you to maintain an active role throughout your transplant and recovery process.

check mark symbol Medically reviewed by Ciara Freeman, MD, PhD, Blood and Marrow Transplant and Cellular Immunotherapy Program

If you’d like to learn more about our approach to blood and bone marrow transplant procedures, you can request an appointment by 1-888-663-3488 or complete a new patient registration form online. You do not need a referral to meet with a blood and bone marrow transplant specialist at Moffitt Cancer Center, where we provide every aspect of treatment and supportive care in a single, convenient location.

  • BMT and CI Leadership
    Frederick  Locke, MD
    Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy
    Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    5 (7)
    Nelli  Bejanyan, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    4.9 (37)
  • Blood and Marrow Transplant and Cellular Immunotherapy
    Melissa  Alsina, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Multiple Myeloma-Plasma Cell Disorders

    4.9 (290)
    Nelli  Bejanyan, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

    4.9 (37)
    Omar  Castaneda Puglianini, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Medical Oncology

    Cancer Focus

    Multiple Myeloma-Plasma Cell Disorders

    5 (29)
    Deepak  Chellapandian, MD, MBBS

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Yehuda  Deutsch, MD

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Rawan  Faramand, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

    5 (37)
    Hugo  Fernandez, MD
    Department Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System
    Program Lead, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Title

    Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Medical Oncology

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS)

    Ciara  Freeman, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Medical Oncology

    Cancer Focus

    Multiple Myeloma-Plasma Cell Disorders

    4.9 (84)
    Nima  Ghalehsari, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    Doris  Hansen, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Multiple Myeloma-Plasma Cell Disorders

    4.8 (43)
    Michael  Jain, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    5 (57)
    Farhad  Khimani, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Benign Hematology, Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    4.9 (33)
    Aleksandr  Lazaryan, MD, MPH, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    4.9 (27)
    Hien  Liu, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma

    4.9 (42)
    Frederick  Locke, MD
    Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy
    Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma

    5 (7)
    Sayeef  Mirza, MD, MPH

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    4.8 (37)
    Asmita  Mishra, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

    4.9 (26)
    Taiga  Nishihori, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia (CML), Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Neurofibromatosis, Non-Hodgkin Lymphoma, Testicular Cancer

    4.9 (50)
    Lia  Perez, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

    4.8 (24)
    Fabiana  Perna, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology

    Cancer Focus

    Graft-vs-Host Disease (GVHD), Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS)

    Joseph  Pidala, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

    5 (50)
    Reshma  Ramlal, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

    5 (20)
    Jose  Sandoval Sus, MD

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Hematology/Oncology

    Cancer Focus

    Chronic Lymphocytic Leukemia (CLL), Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Nancy  Torres Luna, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS)

    4.9 (17)
    Karla  Adams, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Danielle  Baratta, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Chrissy  Copponex, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Marian  Dam, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    KC  Garfield, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    William  Giove, PA

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Erik  Hollers, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Nikita  Hope, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Jessica  Marin, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Disorders, Non-Hodgkin Lymphoma

    4.8 (101)
    Meredith  Markey, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Kristy  Matte, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Catherine  Quealy, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma